OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Jane Street Group LLC

Jane Street Group LLC grew its position in OraSure Technologies, Inc. (NASDAQ:OSURFree Report) by 6.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 296,194 shares of the medical instruments supplier’s stock after acquiring an additional 17,758 shares during the period. Jane Street Group LLC owned about 0.40% of OraSure Technologies worth $1,265,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Millennium Management LLC increased its stake in shares of OraSure Technologies by 727.5% in the 2nd quarter. Millennium Management LLC now owns 2,021,126 shares of the medical instruments supplier’s stock valued at $8,610,000 after purchasing an additional 1,776,867 shares in the last quarter. Acadian Asset Management LLC grew its holdings in OraSure Technologies by 38.1% in the second quarter. Acadian Asset Management LLC now owns 2,195,582 shares of the medical instruments supplier’s stock valued at $9,349,000 after purchasing an additional 605,324 shares during the period. American Century Companies Inc. increased its position in shares of OraSure Technologies by 30.1% in the second quarter. American Century Companies Inc. now owns 1,809,897 shares of the medical instruments supplier’s stock valued at $7,710,000 after buying an additional 418,603 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of OraSure Technologies by 20.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,288,443 shares of the medical instruments supplier’s stock worth $9,749,000 after buying an additional 391,100 shares during the period. Finally, Massachusetts Financial Services Co. MA acquired a new stake in OraSure Technologies in the 2nd quarter valued at $1,602,000. Institutional investors and hedge funds own 93.50% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Monday, December 9th.

View Our Latest Stock Report on OraSure Technologies

OraSure Technologies Trading Down 0.5 %

OSUR stock opened at $3.62 on Friday. The business’s 50-day moving average is $3.96 and its 200 day moving average is $4.16. OraSure Technologies, Inc. has a 12-month low of $3.57 and a 12-month high of $8.45. The stock has a market cap of $270.03 million, a price-to-earnings ratio of 24.13 and a beta of 0.03.

OraSure Technologies (NASDAQ:OSURGet Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The medical instruments supplier reported ($0.06) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.02. OraSure Technologies had a return on equity of 3.55% and a net margin of 5.07%. The firm had revenue of $39.92 million for the quarter, compared to analyst estimates of $38.97 million. During the same period in the previous year, the company posted $0.27 earnings per share. The business’s revenue was down 55.2% on a year-over-year basis. As a group, equities analysts forecast that OraSure Technologies, Inc. will post -0.08 EPS for the current fiscal year.

OraSure Technologies Company Profile

(Free Report)

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.

See Also

Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.